Robert J Motzer Selected Research

Edema (Dropsy)

12/2015	Long-Term Safety With Axitinib in Previously Treated Patients With Metastatic Renal Cell Carcinoma.
4/2012	Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.
5/2007	Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Motzer Research Topics

Disease

252	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 01/2002
134	Neoplasms (Cancer) 04/2024 - 01/2002
39	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2023 - 11/2002
25	Fatigue 04/2023 - 01/2007
21	Kidney Neoplasms (Kidney Cancer) 04/2024 - 08/2004
21	Disease Progression 11/2023 - 01/2002
19	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2003
19	Hypertension (High Blood Pressure) 04/2023 - 11/2007
14	Teratoma (Teratoid Tumor) 10/2019 - 10/2003
11	Testicular Neoplasms (Testicular Cancer) 09/2016 - 11/2003
8	Diarrhea 04/2023 - 01/2007
8	Hypoxia (Hypoxemia) 02/2018 - 12/2006
7	Exanthema (Rash) 10/2019 - 05/2007
6	Hand-Foot Syndrome 04/2023 - 10/2008
5	Stomatitis 01/2020 - 09/2007
5	Nonseminomatous germ cell tumor 08/2018 - 02/2004
4	Body Weight (Weight, Body) 05/2023 - 11/2015
4	Dyspnea (Shortness of Breath) 10/2018 - 06/2008
4	Hyperglycemia 10/2016 - 05/2007
4	Thrombocytopenia (Thrombopenia) 10/2016 - 01/2009
4	Neutropenia 12/2015 - 06/2006
3	Necrosis 01/2023 - 07/2011
3	Tics (Tic) 01/2021 - 10/2015
3	Fibrosis (Cirrhosis) 01/2019 - 01/2002
3	Anemia 07/2017 - 06/2006
3	Embryonal Carcinoma 01/2017 - 10/2003
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017 - 07/2010
3	Edema (Dropsy) 12/2015 - 05/2007
3	Asthenia 12/2015 - 05/2007
3	Carcinoma (Carcinomatosis) 02/2015 - 01/2011
3	Clear-cell metastatic renal cell carcinoma 03/2014 - 05/2013
3	Seminoma 11/2003 - 01/2002
2	Inflammation (Inflammations) 10/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2019
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 10/2020
2	Carcinogenesis 01/2019 - 03/2008
2	Nausea 10/2018 - 09/2007
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017 - 03/2011

Drug/Important Bio-Agent (IBA)

108	Sunitinib (Sutent)FDA Link 04/2024 - 01/2006
47	Everolimus FDA Link 01/2022 - 12/2006
41	NivolumabIBA 01/2024 - 05/2015
39	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 08/2005
33	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2002
32	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2016
23	IpilimumabIBA 01/2024 - 04/2018
21	Tyrosine Kinase InhibitorsIBA 03/2023 - 05/2006
20	Interferon-alpha (Interferon Alfa)IBA 04/2023 - 01/2002
19	cabozantinibIBA 08/2023 - 11/2015
18	Axitinib (AG 013736)IBA 03/2024 - 11/2007
17	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 01/2006
17	Bevacizumab (Avastin)FDA Link 02/2022 - 12/2006
15	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2002
14	pazopanib FDA Link 01/2021 - 08/2013
13	TOR Serine-Threonine KinasesIBA 01/2019 - 09/2007
12	lenvatinibIBA 04/2024 - 11/2015
12	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2002
12	Sorafenib (BAY 43-9006)FDA Link 08/2015 - 12/2006
11	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 12/2010
10	InterferonsIBA 02/2016 - 04/2007
9	CytokinesIBA 01/2018 - 09/2004
8	atezolizumabIBA 02/2022 - 01/2018
8	temsirolimus FDA Link 10/2014 - 12/2006
7	avelumabIBA 02/2024 - 01/2019
6	pembrolizumabIBA 04/2024 - 03/2019
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 09/2005
5	B7-H1 AntigenIBA 01/2022 - 01/2019
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2002
5	PlatinumIBA 10/2019 - 01/2002
5	Ifosfamide FDA LinkGeneric 01/2016 - 09/2005
5	MTOR InhibitorsIBA 04/2014 - 08/2010
4	Carboplatin (JM8)FDA LinkGeneric 09/2023 - 01/2007
4	LigandsIBA 02/2022 - 03/2016
4	Hemoglobins (Hemoglobin)IBA 06/2017 - 10/2006
4	Tumor Biomarkers (Tumor Markers)IBA 10/2014 - 10/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 01/2006
3	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2010
3	Lipase (Acid Lipase)FDA Link 10/2019 - 06/2006
3	Interleukin-2 (IL2)IBA 12/2017 - 08/2008
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 05/2006
3	Alkaline PhosphataseIBA 01/2015 - 10/2006
3	Carbonic Anhydrase IXIBA 10/2014 - 04/2007
2	Programmed Cell Death 1 ReceptorIBA 01/2024 - 02/2018
2	Fumarate Hydratase (Fumarase)IBA 11/2023 - 01/2021
2	MicroRNAs (MicroRNA)IBA 06/2020 - 12/2010
2	Alanine Transaminase (SGPT)IBA 10/2019 - 08/2013
2	Amylases FDA Link 10/2019 - 12/2015
2	NucleotidesIBA 01/2019 - 02/2016
2	Phosphotransferases (Kinase)IBA 10/2018 - 05/2006

Therapy/Procedure

146	Therapeutics 03/2024 - 01/2002
42	Drug Therapy (Chemotherapy) 11/2023 - 01/2002
33	Nephrectomy 01/2024 - 12/2002
23	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 11/2002
17	Immunotherapy 04/2024 - 01/2016
6	Aftercare (After-Treatment) 01/2021 - 06/2003
6	Adjuvant Chemotherapy 01/2020 - 11/2002
4	Salvage Therapy 02/2016 - 01/2007
3	Drug Tapering 03/2015 - 08/2010
3	Radiotherapy 02/2015 - 11/2003
2	Duration of Therapy 10/2016 - 02/2016